Literature DB >> 1109790

Biological behavior of malignant melanoma cells correlated to their survival in vivo.

I J Fidler.   

Abstract

Successive B16 melanoma tumor lines were selected for their ability to form pulmonary tumor nodules. This was accomplished by injecting tumor cells i.v. into syngeneic C57BL/6 mice and 2 to 3 weeks later collecting the secondary tumor growths and placing them into tissue culture. These tumor cells were then injected i.v. into new syngeneic mice and the process was repeated several times. With each successive tumor line the number of experimental lung tumor nodules was significantly increased. The B16 lines were found to be stable in their metastatic properties even after many subculturings in vitro. These studies demonstrated that tumor cells that succeed in forming pulmonary tumor colonies also had increased invasive properties into normal tissues when implanted s.c. In addition, the tumor cell lines were prelabeled in vitro with [125-I]-5-iodo-2'-deoxyuridine and suspensions of labeled cells were injected i.v. into normal syngeneic hosts. Animals were killed at intervals afterwards, and the lungs and blood were processed and monitored for radioactivity. At any time interval, the lungs of mice treated by injections of cells of high metastatic yield contained more tumor cells. The differences in tumor cell numbers in the lungs were most pronounced immediately following i.v. injection. These results suggest that an increased initial arrest of highly metastatic cells in a capillary bed may be a major factor in their increased survival. Low numbers of normal lymphocytes or lymphocytes from syngeneic mice immunized to the B16 melanoma, when mixed in vitro with the tumor cells, lead to the formation of multitumor cell-lymphocyte clumps. The degree of clumping was related to both the type of the metastatic tumor line and/or the syngeneic lymphocyte. These results support the hypothesis that the survival of invasive and/or circulating malignant tumor cells is not a random phenomenon; rather it appears that malignant cells possess unique qualities which allow for their survival.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1109790

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  173 in total

1.  Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.

Authors:  Stéphanie Mercier; Hanne Gahéry-Segard; Martine Monteil; Renée Lengagne; Jean-Gérard Guillet; Marc Eloit; Caroline Denesvre
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours.

Authors:  Johanne Seguin; Céline Nicolazzi; Nathalie Mignet; Daniel Scherman; Guy G Chabot
Journal:  Tumour Biol       Date:  2012-06-07

3.  Localization of the PP2A B56gamma regulatory subunit at the Golgi complex: possible role in vesicle transport and migration.

Authors:  Akihiko Ito; Yu-ichiro Koma; Miwa Sohda; Kenji Watabe; Teruaki Nagano; Yoshio Misumi; Hiroshi Nojima; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 4.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

5.  Modulation of clonal progression in B16F1 melanoma cells.

Authors:  J F Harris; A F Chambers; A S Tam
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

6.  A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects.

Authors:  M Blackmore; S Thompson; G A Turner
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

7.  Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.

Authors:  Chi-Ping Day; John Carter; Carrie Bonomi; Dominic Esposito; Bruce Crise; Betty Ortiz-Conde; Melinda Hollingshead; Glenn Merlino
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-19       Impact factor: 4.693

Review 8.  Pancreatic cancer stem cells: fact or fiction?

Authors:  Vikash J Bhagwandin; Jerry W Shay
Journal:  Biochim Biophys Acta       Date:  2009-02-21

9.  Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.

Authors:  C Andrew Stewart; Hannah Metheny; Noriho Iida; Loretta Smith; Miranda Hanson; Folkert Steinhagen; Robert M Leighty; Axel Roers; Christopher L Karp; Werner Müller; Giorgio Trinchieri
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

10.  Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

Authors:  J H Sampson; G E Archer; D M Ashley; H E Fuchs; L P Hale; G Dranoff; D D Bigner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.